Comparison

TuSaludVirtual vs Jovie Study

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

TuSaludVirtual

Connect with your healthcare provider through secure text messaging, video calls, and asynchronous question-based visits. This telemedicine solution enhances efficient communication between patients and providers from a mobile device.

Highlights
  • Secure text messaging
  • Video visits
  • Asynchronous question-based visits
  • HIPAA compliant
  • Provider-patient communication
Features
Read full description

TuSaludVirtual is a product by Primary Physicians Care, PSC that makes connecting with your Provider quicker and easier from the convenience of your mobile device. TuSaludVirtual offers a telemedicine solution that allows Providers and Patients to communicate more efficiently by using secure, HIPAA compliant text messaging, video visits and question-based asynchronous visits. Featuring asynchronous and video visits, TuSaludVirtual is a comprehensive telemedicine app that provides the most valuable features. TusaludVirtual is a register trade mark of Primacy Physician Care, PSC in Puerto Rico.

About

Jovie Study

This app facilitates participation in a clinical trial for infant formula, allowing subjects to manage study tasks and data collection remotely. It streamlines the research process by eliminating physical site visits, ensuring robust data collection and increased participant compliance.

Highlights
  • Remote clinical trial management
  • Infant formula study participation
  • Data collection and surveys
  • Secure chat with study team
  • Informed consent process
  • Daily task completion
Features
Read full description

Welcome to the Jovie Study: The Jovie app is a proprietary platform of ObvioHealth being used to manage a trial to study use of an investigational infant formula and how it affect infant growth and tolerance in comparison to current market formula or breast milk.  The Jovie app removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.  The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.  Subject Journey A subject who is identified as eligible for this study during pre-screening will be invited to download the Jovie App via e-mail.  Upon download, the participants create a Jovie account and complete the Informed Consent process. A series of screens explains the parameters of the study, including:  o Privacy Policy  o Data Gathering & Usage  o Study Tasks & Surveys  o Time Commitment  o Option to Withdraw  Subjects will have the opportunity to connect with a member of the study team to ask questions prior to signing the informed consent form.  Intervention Period:Daily Tasks Subjects will contribute data to the study by completing questionnaires and data uploads over a 5-day baseline period and 16-week active trial period. Subjects can interact with the study team via secure chat as needed.

Screenshots

TuSaludVirtual3 screens
Jovie Study4 screens

Verdict

The call

The clearest difference is review sentiment: TuSaludVirtual at 100% against Jovie Study's 0%. TuSaludVirtual also leads on rating (4.6 vs 2.5) and ratings volume (18 vs 2). Jovie Study's advantage is update cadence (every 3 weeks vs every 2 months). On price, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

TuSaludVirtual holds the better App Store score, 4.6 against 2.5. That said, the two scores are not equally well evidenced: TuSaludVirtual has 18 ratings behind it against 2, so its average is the more settled of the two. Written reviews point the same way: 100% of TuSaludVirtual's written reviews are positive against 0% of Jovie Study's.

UpkeepUpdate frequency

TuSaludVirtual ships an update every 2 months, Jovie Study every 3 weeks. The most recent releases landed on October 24, 2026 and October 21, 2026 respectively.

Scorecard4 real differences · 6 level
TuSaludVirtual versus Jovie Study: the parameters behind the verdict, then further details
ParameterTuSaludVirtualJovie Study
PriceFreeFree
Rating4.6 (18 ratings) — better2.5 (2 ratings)
Positive reviews100.0% of reviews — better0.0% of reviews
Number of ratings18 — better2
Update frequencyEvery 2 monthsEvery 3 weeks — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS12.011.0 — better
Further details — not scored
Size152 MB62 MB
Age rating17+4+
DeveloperPrimary Physician Care, PSC.Obvio Health USA Inc.

Customer experience

TuSaludVirtual

All ratings17 ratings
Positive94.1%
Neutral0.0%
Negative5.9%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

Jovie Study

All ratings2 ratings
Positive50.0%
Neutral0.0%
Negative50.0%
Written reviews1 reviews
Positive0.0%
Neutral0.0%
Negative100.0%

In-app purchases

None

TuSaludVirtual

No in-app purchases

None

Jovie Study

No in-app purchases

Questions

Is TuSaludVirtual free?
TuSaludVirtual is free to download, with no in-app purchases.
Is Jovie Study free?
Jovie Study is free to download, with no in-app purchases.
Which has better reviews, TuSaludVirtual or Jovie Study?
TuSaludVirtual is rated higher. TuSaludVirtual averages 4.6 out of 5 from 18 ratings, while Jovie Study averages 2.5 from 2 ratings.
Do TuSaludVirtual or Jovie Study have ads?
Neither TuSaludVirtual nor Jovie Study shows ads.
Which is updated more often, TuSaludVirtual or Jovie Study?
TuSaludVirtual ships an update every 2 months, and Jovie Study every 3 weeks. Most recently, TuSaludVirtual was updated on October 24, 2026 and Jovie Study on October 21, 2026.

Other comparisons